International journal of infectious diseases, 2017-06, Vol.59 (C), p.118-123
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- CLINICAL EFFICACY OF CEFTAZIDIME/AVIBACTAM VERSUS OTHER ACTIVE AGENTS FOR THE TREATMENT OF BACTEREMIA DUE TO CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE IN HEMATOLOGIC PATIENTS
- Ist Teil von
- International journal of infectious diseases, 2017-06, Vol.59 (C), p.118-123
- Ort / Verlag
- Canada: Elsevier Ltd
- Erscheinungsjahr
- 2017
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Highlights • The majority of CPE corresponded to OXA-48 isolations. • CPE bacteremia is associated with high mortality in hematologic patients. • Mortality was associated with septic shock and higher Pitt score. • Therapy with ceftazidime/avibactam was not associated with increased survival. • Patients who received ceftazidime/avibactam had higher clinical cure rates
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1201-9712eISSN: 1878-3511DOI: 10.1016/j.ijid.2017.03.021Titel-ID: cdi_doaj_primary_oai_doaj_org_article_dd2025110a534a30aa898d61e38b3caa
- Format
- –
- Schlagworte
- Anti-Bacterial Agents - therapeutic use, Azabicyclo Compounds - therapeutic use, Bacteremia - complications, Bacteremia - drug therapy, Bacteremia - microbiology, Bacterial Proteins - biosynthesis, beta-Lactamases - biosynthesis, Bloodstream infections, Carbapenemase-producing Enterobacteriaceae, Ceftazidime - therapeutic use, Ceftazidime-avibactam, Cohort Studies, Drug Therapy, Combination, Enterobacteriaceae - enzymology, Enterobacteriaceae Infections - drug therapy, Female, Hematologic Neoplasms - complications, Humans, Infectious Disease, Male, Microbial Sensitivity Tests, Middle Aged, Pulmonary/Respiratory, Retrospective Studies, Treatment Outcome